High-throughput single-сell sequencing in cancer research

Q Jia, H Chu, Z Jin, H Long, B Zhu - Signal Transduction and Targeted …, 2022 - nature.com
With advances in sequencing and instrument technology, bioinformatics analysis is being
applied to batches of massive cells at single-cell resolution. High-throughput single-cell …

[HTML][HTML] Vector-based genetically modified vaccines: Exploiting Jenner's legacy

B Ramezanpour, I Haan, A Osterhaus, E Claassen - Vaccine, 2016 - Elsevier
The global vaccine market is diverse while facing a plethora of novel developments. Genetic
modification (GM) techniques facilitate the design of'smarter'vaccines. For many of the major …

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

KA Collins, R Snaith, MG Cottingham, SC Gilbert… - Scientific reports, 2017 - nature.com
The leading malaria vaccine in development is the circumsporozoite protein (CSP)-based
particle vaccine, RTS, S, which targets the pre-erythrocytic stage of Plasmodium falciparum …

[HTML][HTML] Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

RO Payne, SE Silk, SC Elias, K Miura, A Diouf… - JCI insight, 2017 - ncbi.nlm.nih.gov
The development of a highly effective vaccine remains a key strategic goal to aid the control
and eventual eradication of Plasmodium falciparum malaria. In recent years, the reticulocyte …

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum …

C Ogwang, D Kimani, NJ Edwards, R Roberts… - Science translational …, 2015 - science.org
Protective immunity to the liver stage of the malaria parasite can be conferred by vaccine-
induced T cells, but no subunit vaccination approach based on cellular immunity has shown …

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

SE Silk, WF Kalinga, IM Mtaka, NS Lilolime, M Mpina… - Med, 2023 - cell.com
Background RH5 is a leading blood-stage candidate antigen for a Plasmodium falciparum
vaccine; however, its safety and immunogenicity in malaria-endemic populations are …

Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a phase I first-in-human trial

H De Graaf, RO Payne, I Taylor, K Miura… - Frontiers in …, 2021 - frontiersin.org
Background Transmission blocking vaccines targeting the sexual-stages of the malaria
parasite could play a major role to achieve elimination and eradication of malaria. The …

A monovalent chimpanzee adenovirus Ebola vaccine—preliminary report

T Rampling, K Ewer, G Bowyer, D Wright… - New England Journal …, 2015 - ora.ox.ac.uk
Background The West African outbreak of Ebola virus disease has caused more than 8500
deaths. A vaccine could contribute to outbreak control in the region. We assessed a …

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara …

T Rampling, KJ Ewer, G Bowyer… - The Journal of …, 2016 - academic.oup.com
Background. The need for a highly efficacious vaccine against Plasmodium falciparum
remains pressing. In this controlled human malaria infection (CHMI) study, we assessed the …

Recent advances in the development of adenovirus-vectored vaccines for parasitic infections

C Koger-Pease, DJ Perera, M Ndao - Pharmaceuticals, 2023 - mdpi.com
Vaccines against parasites have lagged centuries behind those against viral and bacterial
infections, despite the devastating morbidity and widespread effects of parasitic diseases …